Data / Form D filings / Etheros Pharmaceuticals Corp.
Etheros Pharmaceuticals Corp.: Form D filings
Etheros Pharmaceuticals Corp., a pharmaceuticals company in Nashville, TN, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on June 10, 2025, reports $600,000 sold of a $600,000 offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 111 10TH AVE S, STE 110, Nashville, TN, 37203
- Phone
- (615) 212-9695
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2005132
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | New notice | $600,000 | $600,000 | 6 | Jan 31, 2025 | sec.gov | |
| Dec 20, 2023 | New notice | $300,000 | $300,000 | 2 | Nov 6, 2023 | sec.gov | |
| Dec 20, 2023 | New notice | $775,000 | $775,000 | 5 | Feb 20, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Subhasish William Chakraborty | Executive Officer | |
| John William Scannell | Executive Officer, Director | |
| Marc William Feldmann | Director | |
| Francis William Knuettel II | Director | |
| Laura William Dugan | Director |
Every Form D from the week of Jun 9, 2025 · All recent filings in Tennessee · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Etheros Pharmaceuticals Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.